The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab with chemotherapy in pleural mesothelioma after surgery: The NICITA trial.
 
Rajiv Shah
Honoraria - AstraZeneca; Roche
Research Funding - Bristol Myers Squibb GmbH & Co.KGaA (Inst)
 
Laura V. Klotz
No Relationships to Disclose
 
Daniel Christian Christoph
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ipsen; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ipsen; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ipsen; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda
Expert Testimony - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ipsen; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ipsen; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda
 
Karsten Schulmann
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Janssen-Cilag; Merck; Novartis; Roche
Speakers' Bureau - Abbvie; Janssen-Cilag; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Janssen-Cilag
 
Hans-Georg Kopp
Honoraria - AstraZeneca; BMS; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; PharmaMar; Roche; Sanofi
 
Niels Reinmuth
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Janssen
 
Michael Ried
Research Funding - MSD (Inst)
 
Maike de Wit
Employment - Vivantes Network for Health
Speakers' Bureau - AstraZeneca; Ipsen; Janssen; Sanofi
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genzyme (Inst); Ipsen (Inst); Janssen (Inst); MorphoSys (Inst); MSD (Inst); Noona Healthcare (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Pierre Fabre (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Pfizer; Takeda
 
Eva Lotte Buchmeier
Consulting or Advisory Role - Ipsen; Takeda
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly O. (Inst); Mirati Therapeutics (Inst); MSD (Inst); Novartis (Inst); PDC Line Pharma (Inst); Razor Genomics (Inst)
Travel, Accommodations, Expenses - MSD; Takeda
 
Claas Wesseler
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly O.; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis; Sanofi/Regeneron
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Andre Bethge
No Relationships to Disclose
 
Cornelius Waller
Consulting or Advisory Role - Alvotech; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai/Roche; Lilly; Merck; MSD; Mylan; Novartis/Ipsen; Pfizer; Roche; Takeda; Vifor Pharma; Vifor Pharma
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; IPSEN
 
Petra Hoffknecht
Honoraria - AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; MSD; Roche; Takeda
 
Bjoern Hackanson
Honoraria - Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche
 
Marc A. Schneider
Patents, Royalties, Other Intellectual Property - Patent US No 16/206,526
 
Rouven Behnisch
No Relationships to Disclose
 
Petros Christopoulos
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); Roche (Inst); Takeda (Inst)
 
Martin E. Eichhorn
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - AstraZeneca; MSD; Roche
Research Funding - MSD (Inst)
 
Michael Thomas
Honoraria - AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly O.; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly O.; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen Oncology; Lilly O.; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda